| 1/3 | US=96 / Biol/Mol Scola L, Giacalone A, Marasà L, Mirabile M, Vaccarino L, Forte GI, Giannitrapani L, Caruso C, Montalto G, Lio D. Genetic determined downregulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 284-8. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. CANCER DE PANCREAS; POLIMORFISMOS DOS GENES; IL-4R&*945;; IL-10 |
| 2/3 | US=93 / Biol/Mol Fujii SI, Lotze MT. Cytokines and carcinogenesis: interleukin-10 (IL-10). In: Caligiuri MA, Lotze MT. Cytokines in the genesis and treatment of cancer. New Jersey: Humana Press, 2007. p. 165-79. (Cancer Drug Discovery and Development) ISBN 978-0-89603-820-2. |
| 3/3 | US=47 / Clín/Medica Crivello A, Giacalone A, Vaglica M, Scola L, Forte GI, Macaluso MC, Raimondi C, Di Noto L, Bongiovanni A, Accardo A, Candore G, Palmeira S. Regulatory cytokine gene polymorphism and risk of colorectal carcinoma. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 98-103. ISBN 978-1-57331-699-5. RISCO DE CARCINOMA COLORRETAL; CANCER COLORRETAL; POLIMORFISMO DO GENE; TGF-B1; IL-10 |